Psychopharmacology

, Volume 225, Issue 2, pp 313–327

Alcohol in excess: CRF1 receptors in the rat and mouse VTA and DRN

  • Lara S. Hwa
  • Joseph F. DeBold
  • Klaus A. Miczek
Original Investigation

Abstract

Rationale

Manipulation of the stress neuropeptide corticotropin-releasing factor (CRF), specifically central antagonism of the type 1 receptors (CRF-R1), effectively reduces alcoholic-like ethanol drinking in rodents. Escalated consumption is largely controlled by neurocircuitry that is important for reward and affect, such as the ventral tegmental area (VTA) and the dorsal raphé nucleus (DRN).

Objective

The current studies investigated the role of CRF-R1 within the VTA and DRN and their relation to escalated ethanol drinking in two species. An additional goal was to explore whether high alcohol-drinking individuals would be more affected by CRF-R1 antagonism than low alcohol-drinking individuals.

Methods

With a two-bottle choice drinking procedure, adult male C57BL/6J mice and Long–Evans rats were given 24-h access to 20 % ethanol and water on an intermittent schedule. Rats and mice were implanted with cannulae targeting the VTA or DRN. Doses of the CRF-R1 antagonist CP-154,526 (butyl-[2,4,6-trimethylphenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]ethylamine)) were microinfused to modulate drinking of ethanol and water over the course of 24 h.

Results

In both mice and rats, intra-VTA CP-154,526 selectively decreased ethanol intake, while identical doses (0.3 and 0.6 μg) infused intra-DRN reduced both ethanol and water drinking. Long–Evans rats displayed a range of individual differences for ethanol preference, and CP-154,526 suppressed ethanol drinking in the high-preferring animals regardless of brain site manipulation.

Conclusions

The current findings confirm previous studies that blockade of CRF-R1 efficaciously reduces escalated drinking while also suggesting that the effects of intermittent access on alcohol consumption may require CRF interaction with dopamine in the VTA.

Keywords

Alcohol CRF VTA Dorsal raphe Drinking 

References

  1. Becker HC (1998) Kindling in alcohol withdrawal. Alcohol Health Res World 22:25–33PubMedGoogle Scholar
  2. Beckstead MJ, Gantz SC, Ford CP, Stenzel-Poore MP, Phillips PEM, Mark GP, Williams JT (2009) CRF enhancement of GIRK channel-mediated transmission in dopamine neurons. Neuropsychopharmacology 34:1926–1935PubMedCrossRefGoogle Scholar
  3. Berman RF, Cannon DS (1974) The effect of prior ethanol experience on ethanol-induced saccharin aversions. Physiol Behav 12:1041–1044PubMedCrossRefGoogle Scholar
  4. Boyson CO, Miguel TT, Quadros IM, DeBold JF, Miczek KA (2011) Prevention of social stress-escalated cocaine self-administraiton by CRF-R1 antagonist in the rat VTA. Psychopharmacology 218:257–269PubMedCrossRefGoogle Scholar
  5. Branchey L, Shaw S, Lieber CS (1981) Ethanol impairs tryptophan transport into the brain and depresses serotonin. Life Sci 29:2751–2755PubMedCrossRefGoogle Scholar
  6. Brodie MS, Appel SB (2000) Dopaminergic neurons in the ventral tegmental area of C57BL/6J and DBA/2J mice differ in sensitivity to ethanol excitation. Alcohol Clin Exp Res 24:1120–1124PubMedCrossRefGoogle Scholar
  7. Carlsson A, Engel J, Strombom U, Svensson TH, Waldeck B (1974) Suppression by dopamine-agonists of the ethanol-induced stimulation of locomotor activity and brain dopamine synthesis. Naunyn Schmiedebergs Arch Pharmacol 283:117–128PubMedCrossRefGoogle Scholar
  8. Chalmers DT, Lovenberg TW, De Souza EB (1995) Localization of novel corticotroin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression. J Neurosci 15:6340–6350PubMedGoogle Scholar
  9. Chen C (2006) Recent advances in small molecule antagonists of the corticotropin-releasing factor type-1 receptor—focus on pharmacology and pharmacokinetics. Curr Med Chem 13:1261–1282PubMedCrossRefGoogle Scholar
  10. Chu K, Koob GF, Cole M, Zorrilla EP, Roberts AJ (2007) Dependence-induced increases in ethanol self-administration in mice are blocked by the CRF1 receptor antagonist antalarmin and by CRF1 receptor knockout. Pharmacol Biochem Behav 86:813–821PubMedCrossRefGoogle Scholar
  11. Cippitelli A, Damadzic R, Singley E, Thorsell A, Ciccocioppo R, Eskay RL, Heilig M (2012) Pharmacological blockade of corticotropin-releasing hormone receptor 1 (CRH1R) reduces voluntary consumption of high concentrations in non-dependent Wistar rats. Pharmacol Biochem Behav 100: 522–529Google Scholar
  12. Contarino A, Dellu F, Koob GF, Smith GW, Lee KF, Vale WW et al (2000) Dissociation of locomotor activation and suppression of food intake induced by CRF in CRFR1-deficient mice. Endocrinology 141:2698–2702PubMedCrossRefGoogle Scholar
  13. D’Este L, Casini A, Puglisi-Allegra S, Cabib S, Renda TG (2007) Comparative immunohistochemical study of the dopaminergic systems in two inbred mouse strains (C57BL/6J and DBA/2J). J Chem Neuroanat 33:67–74PubMedCrossRefGoogle Scholar
  14. Deutch AY, Bean AJ, Bissette G, Nemeroff CB, Robbins RJ, Roth RH (1987) Stress-induced alterations in neurotensin, somatostatin and corticotropin-releasing factor in mesotelencephalic dopamine system regions. Brain Res 417:350–354PubMedCrossRefGoogle Scholar
  15. Deutch AY, Lee MC, Gillham MH, Cameron DA, Goldstein M, Iadarola MJ (1991) Stress selectively increases fos protein in dopamine neurons innervating the prefrontal cortex. Cereb Cortex 1:273–292PubMedCrossRefGoogle Scholar
  16. Diana M, Gessa GL, Rossetti ZL (1992) Lack of tolerance to ethanol-induced stimulation of mesolimbic dopamine system. Alcohol Alcohol 27:329–333PubMedGoogle Scholar
  17. DiChiara G, Imperato A (1988) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci U S A 85:5274–5278CrossRefGoogle Scholar
  18. Finn DA, Snelling C, Fretwell AM, Tanchuck MA, Underwood L, Cole M et al (2007) Increased drinking during withdrawal from intermittent ethanol exposure is blocked by the CRF receptor antagonist d-Phe-CRF(12-41). Alcohol Clin Exp Res 31:939–949PubMedCrossRefGoogle Scholar
  19. Fuller JL (1964) Measurement of alcohol preference in genetic experiments. J Comp Physiol Psychol 57:85–88PubMedCrossRefGoogle Scholar
  20. Funk CK, Koob GF (2007) A CRF(2) agonist administered into the central nucleus of the amygdala decreases ethanol self-administration in ethanol-dependent rats. Brain Res 1155:172–178PubMedCrossRefGoogle Scholar
  21. Funk CK, Zorrilla EP, Lee MJ, Rice KC, Koob GF (2007) Corticotropin-releasing factor 1 antagonists selectively reduce ethanol self-administration in ethanol-dependent rats. Biol Psychiatry 61:78–86PubMedCrossRefGoogle Scholar
  22. Gatto GJ, McBride WJ, Murphy JM, Lumeng L, Li TK (1994) Ethanol self-infusion into the ventral tegmental area by alcohol-preferring rats. Alcohol 11:557–564PubMedCrossRefGoogle Scholar
  23. Gehlert DR, Cippitelli A, Thorsell A, Le AD, Hipskind PA, Hamdouchi C et al (2007) 3-(4-Chloro-2-morpholin-4-yl-thiazol-5-yl)-8-(1-ethylpropyl)-2,6-dimethyl-imidazo[1,2-b]pyridazine: a novel brain-penetrant, orally available corticotropin-releasing factor receptor 1 antagonist with efficacy in animal models of alcoholism. J Neurosci 27:2718–2726PubMedCrossRefGoogle Scholar
  24. Gessa GL, Muntoni F, Collu M, Vargiu L, Mereu G (1985) Low doses of ethanol activate dopaminergic neurons in the ventral tegmental area. Brain Res 348:201–203PubMedCrossRefGoogle Scholar
  25. Giardino WJ, Cocking DL, Kaur S, Cunningham CL, Ryabinin AE (2011) Urocortin-1 within the centrally-projecting Edinger–Westphal nucleus is critical for ethanol preference. PLoS One 6:e26997PubMedCrossRefGoogle Scholar
  26. Gilpin NW, Richardson HN, Koob GF (2008) Effects of CRF(1)-receptor and opioid-receptor antagonists on dependence-induced increases in alcohol drinking by alcohol-preferring (P) rats. Alcohol Clin Exp Res 32: 1535–1542Google Scholar
  27. Goldstein DB, Kakihana R (1977) Circadian rhythms of ethanol consumpton in mice: a simple computer analysis for chronopharmacology. Psychopharmacology 52:41–45PubMedCrossRefGoogle Scholar
  28. Gonzales RA, Job MO, Doyon WM (2004) The role of mesolimbic dopamine in the development and maintenance of ethanol reinforcement. Pharmacol Ther 103:121–146PubMedCrossRefGoogle Scholar
  29. Graeff FG, Guimaraes FS, De Andrade TG, Deakin JF (1996) Role of 5-HT in stress, anxiety, and depression. Pharmacol Biochem Behav 54:129–141PubMedCrossRefGoogle Scholar
  30. Hansson AC, Cippitelli A, Sommer WH, Fedeli A, Björk K, Soverchia L et al (2006) Variation at the rat Crhr1 locus and sensitivity to relapse into alcohol seeking induced by environmental stress. Proc Nat Acad Sci 103:15236–15241PubMedCrossRefGoogle Scholar
  31. Hauger RL, Risbrough V, Brauns O, Dautzenberg FM (2006) Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: new molecular targets. CNS Neurol Disord Drug Targets 5:453–479PubMedCrossRefGoogle Scholar
  32. Hauser SR, Ding ZM, Getachew B, Toalson JE, Oster SM, McBride WJ, Rodd ZA (2011) The posterior ventral tegmental area mediates alcohol-seeking behavior in alcohol-preferring rats. J Pharmacol Exp Ther 336:857–865PubMedCrossRefGoogle Scholar
  33. Heinrichs SC, Richard D (1999) The role of corticotropin-releasing factor and urocortin in the modulation of ingestive behavior. Neuropeptides 33:350–359PubMedCrossRefGoogle Scholar
  34. Hwa LS, Chu A, Levinson SA, Kayyali TM, DeBold JF, Miczek KA (2011a) Persistent escalation of alcohol drinking in C57BL/6J mice with intermittent access to 20 % ethanol. Alcohol Clin Exp Res 35:1938–1947PubMedCrossRefGoogle Scholar
  35. Hwa LS, Kayyali T, DeBold JF, Miczek KA (2011b) Excessive alcohol drinking in C57BL/6J mice due to intermittent access to alcohol: influence of CRF and opioid systems. Research Abstract for Res Soc Alcoholism Annual Scientific Meeting. Alcohol Clin Exp Res 6(Suppl):69AGoogle Scholar
  36. Jacobs BL, Azmitia EC (1992) Structure and function of the brain serotonin system. Physiol Rev 72:165–229PubMedGoogle Scholar
  37. Kauer JA (2004) Learning mechanisms in addiction: synaptic plasticity in the ventral tegmental area as a result of exposure to drugs of abuse. Annu Rev Physiol 66:447–475PubMedCrossRefGoogle Scholar
  38. Kauer JA, Malenka RC (2007) Synaptic plasticity and addiction. Nat Rev Neurosci 8:844–858PubMedCrossRefGoogle Scholar
  39. Kehne JH (2007) The CRF1 receptor, a novel target for the treatment of depression, anxiety, and stress-related disorders. CNS Neurol Disord Drug Targets 6:163–182PubMedCrossRefGoogle Scholar
  40. Keifer SW, Bice PJ, Badia-Elder N (1994) Alterations in taste reactivity to alcohol in rats given continuous alcohol access followed by abstinence. Alcohol Clin Exp Res 18:555–559CrossRefGoogle Scholar
  41. Kirby LG, Rice KC, Valentino RJ (2000) Effects of corticotropin-releasing factor on neuronal activity in the serotonergic dorsal raphe nucleus. Neuropsychopharmacology 22:148–162PubMedCrossRefGoogle Scholar
  42. Koob GF (2003) Neuroadaptive mechanisms of addiction: studies on the extended amygdala. Eur Neuropsychopharmacol 13:442–452PubMedCrossRefGoogle Scholar
  43. Koob GF, Le Moal ML (1997) Drug abuse: hedonic homeostatic dysregulation. Science 278:52–59PubMedCrossRefGoogle Scholar
  44. Koob GF, Heinrichs SC, Pich EM, Menzaghi F, Baldwin H, Miczek KA et al (1992) The role of corticotropin-releasing factor in behavioural responses to stress. CIBA Found Symp 172:277–295Google Scholar
  45. Korotkova TM, Brown RE, Sergeeva OA, Ponomarenko AA, Haas HL (2006) Effects of arousal- and feeding-related neuropeptides on dopaminergic and GABAergic neurons in the ventral tegmental area of the rat. Eur J Neurosci 23:2677–2685PubMedCrossRefGoogle Scholar
  46. LeMarquand D, Pihl RO, Benkelfat C (1994) Serotonin and alcohol intake, abuse, and dependence: findings of animal studies. Biol Psychiatry 36:395–421CrossRefGoogle Scholar
  47. Lodge DJ, Grace AA (2005) Acute and chronic corticotropin-releasing factor 1 receptor blockade inhibits cocaine-induced dopamine release: correlation with dopamine neuron activity. J Pharmacol Exp Ther 314:201–206PubMedCrossRefGoogle Scholar
  48. Lowery EG, Thiele TE (2010) Pre-clinical evidence that corticotropin-releasing factor (CRF) receptor antagonists are promising targets for pharmacological treatment of alcoholism. CNS Neurol Disord Drug Targets 9:77–86PubMedCrossRefGoogle Scholar
  49. Lowery-Gionta EG, Navarro M, Li C, Pliel KE, Rinker JA, Cox BR, Sprow GM, Kash TL, Thiele TE (2012) Corticotropin releasing factor signaling in the central amygdala is recruited during binge-like ethanol consumption in C57BL/6J mice. J Neurosci 32:3405–3413PubMedCrossRefGoogle Scholar
  50. Lundkvist J, Chai Z, Teheranian R, Hasanvan H, Bartfai T, Jenck F et al (1996) A non-peptidic corticotropin releasing factor receptor antagonist attenuates fever and exhibits anxiolytic-like activity. Eur J Pharmacol 309:195–200PubMedCrossRefGoogle Scholar
  51. McClearn GE, Rodgers DA (1959) Differences in alcohol preference among inbred strains of mice. Q J Stud Alcohol 20:691–695Google Scholar
  52. Melendez RI (2011) Intermittent (every-other-day) drinking induces rapid escalation of ethanol intake and preference in adolescent and adult C57BL/6J mice. Alcohol Clin Exp Res 35:652–658PubMedCrossRefGoogle Scholar
  53. Melon LC, Boehm SL (2011) GABAA receptors in the posterior, but not anterior, ventral tegmental area mediate Ro15-4513-induced attenuation of binge-like ethanol consumption in C57BL/6J female mice. Behav Brain Res 220:230–237PubMedCrossRefGoogle Scholar
  54. Menzaghi F, Howard RL, Heinrichs SC, Vale W, Rivier J, Koob GF (1994) Characterization of a novel and poten corticotropin-releasing factor antagonist in rats. J Pharmacol Exp Ther 269:564–572PubMedGoogle Scholar
  55. Merlo-Pich PE, Lorang M, Yeganeh M, Rodriguez dF, Raber J, Koob GF et al (1995) Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis. J Neurosci 15:5439–5447PubMedGoogle Scholar
  56. Molliver ME (1987) Serotonergic neuronal systems: what their anatomic organization tells us about function. J Clin Psychopharmacol 7:3S–23SPubMedCrossRefGoogle Scholar
  57. Paxinos G, Franklin K (2003) The mouse brain in stereotaxic coordinates. Elsevier Academic, San DiegoGoogle Scholar
  58. Paxinos G, Watson C (1997) The rat brian in stereotaxic coordinates. Academic, San DiegoGoogle Scholar
  59. Pelleymounter MA, Joppa M, Carmouche M, Cullen MJ, Brown B et al (2000) Role of corticotropin-releasing factor (CRF) receptors in the anorexic syndrom induced by CRF. J Pharmacol Exp Ther 293:799–806PubMedGoogle Scholar
  60. Pfeffer AO, Samson HH (1986) Effect of pimozide on home cage ethanol drinking in the rat: dependence on drinking session length. Drug Alcohol Depend 17:47–55PubMedCrossRefGoogle Scholar
  61. Pinel JP, Huang E (1976) Effects of periodic withdrawal on ethanol and saccharin selection in rats. Physiol Behav 16:693–698PubMedCrossRefGoogle Scholar
  62. Price ML, Lucki I (2001) Regulation of serotonin release in the lateral septum and striatum by corticotropin-releasing factor. J Neurosci 21:2833–2841PubMedGoogle Scholar
  63. Price ML, Curtis AL, Kirby LJ, Valentino RJ, Lucki I (1998) Effects of corticotropin-releasing factor on brain serotonergic activity. Neuropsychopharmacology 18:492–502PubMedCrossRefGoogle Scholar
  64. Rassnick S, Stinus L, Koob GF (1993) The effects of 6-hydroxydopamine lesions of the nucleus accumbens and the mesolimbic dopamine system on oral self-administration of ethanol in the rat. Brain Res 623:16–24PubMedCrossRefGoogle Scholar
  65. Rhodes JS, Best K, Belknap JK, Finn DA, Crabbe JC (2005) Evaluation of a simple model of ethanol drinking to intoxicaiton in C57BL/6J mice. Physiol Behav 84:53–63PubMedCrossRefGoogle Scholar
  66. Richardson HN, Zhao Y, Fekete EM, Funk CK, Wirsching P, Janda KD, Zorrilla EP, Koob GF (2008) MPZP: a novel small molecule corticotropin-releasing factor type 1 receptor (CRF1) antagonist. Pharmacol Biochem Behav 88:497–510PubMedCrossRefGoogle Scholar
  67. Rodd ZA, Bell RL, Melendez RI, Kuc KA, Lumeng L, Li TK et al (2004) Comparison of intracranial self-administration of ethanol within the posterior ventral tegmental area between alcohol-preferring and Wistar rats. Alcohol Clin Exp Res 28:1212–1219PubMedCrossRefGoogle Scholar
  68. Rossetti ZL, Hmaidan Y, Gessa GL (1992) Marked inhibition of mesolimbic dopamine release: a common feature of ethanol, morphine, cocaine and amphetamine abstinence in rats. Eur J Pharmacol 221:227–234PubMedCrossRefGoogle Scholar
  69. Ryabinin AE, Weitemier AZ (2006) The urocortin 1 neurocircuit: ethanol-sensitivity and potential involvement in alcohol consumption. Brain Res Rev 52:368–380PubMedCrossRefGoogle Scholar
  70. Sabino V, Cottone P, Koob GF, Steardo L, Lee MJ, Rice KC, Zorrilla EP (2006) Dissociation between opioid and CRF1 antagonist sensitive drinking in Sardinian alcohol-preferring rats. Psychopharmacology 189:175–186PubMedCrossRefGoogle Scholar
  71. Sakanaka M, Shibasaki T, Lederis K (1986) Distribution and efferent projections of corticotropin-releasing factor-like immunoreactivity in the rat amygdaloid complex. Brain Res 382:213–238PubMedCrossRefGoogle Scholar
  72. Schulz DW, Mansbach RS, Sprouse J, Braselton JP, Collins J, Corman M et al (1996) CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors. Proc Natl Acad Sci U S A 93:10477–10482PubMedCrossRefGoogle Scholar
  73. Sharpe AL, Phillips TJ (2009) Central urocortin 3 administraiton decrases limited access ethanol intake in non-dependent mice. Behav Pharmacol 20:326–351CrossRefGoogle Scholar
  74. Shen RY, Chiodo LA (1993) Acute withdrawal after repeated ethanol treatment reduces the number of spontaneously active dopaminergic neurons in the ventral tegmental area. Brain Res 622:289–293PubMedCrossRefGoogle Scholar
  75. Simms JA, Steensland P, Medina B, Abernathy KE, Chandler LJ, Wise R et al (2008) Intermittent access to 20 % ethanol induces high ethanol consumption in Long–Evans and Wistar rats. Alcohol Clin Exp Res 32:1816–1823PubMedCrossRefGoogle Scholar
  76. Sinclair JD, Senter RJ (1968) Development of an alcohol-deprivation effect in rats. Q J Stud Alcohol 29:863–867PubMedGoogle Scholar
  77. Smith SM, Vale WW (2006) The role of the hypothalamic–pituitary–adrenal axis in neuroendocrine responses to stress. Dialogues Clin Neurosci 8:383–395PubMedGoogle Scholar
  78. Spanagel R, Weiss F (1999) The dopamine hypothesis of reward: past and current studies. Trends Neurosci 22:521–527PubMedCrossRefGoogle Scholar
  79. Sparta DR, Sparrow AM, Lowery EG, Fee JR, Knapp DJ, Thiele TE (2008) Blockade of corticotropin releasing factor type 1 receptor attenuates elevated ethanol drinking associated with drinking in the dark procedures. Alcohol Clin Exp Res 32:259–265PubMedCrossRefGoogle Scholar
  80. Spina M, Merlo-Pich E, Chan RKW, Basso AM, Rivier J, Vale W, Koob GF (1996) Appetite-suppressing effects of urocortin, a CRF-related neuropeptide. Science 273:1561–1564PubMedCrossRefGoogle Scholar
  81. Swanson LW, Sawchenko PE, Rivier J, Vale WW (1983) Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology 36:165–186PubMedCrossRefGoogle Scholar
  82. Tabakoff B, Ritzmann RF (1975) Inhibition of the transport of 5-hydroxyindoleacetic acid from brain by ethanol. J Neurochem 24:1043–1051PubMedCrossRefGoogle Scholar
  83. Tagliaferro P, Morales M (2008) Synapses between corticotropin-releasing factor-containing axon terminals and dopaminergic neurons in the ventral tegmental area are predominantly glutamatergic. J Comp Neurol 506:616–626PubMedCrossRefGoogle Scholar
  84. Thierry AM, Tassin JP, Blanc G, Glowinski J (1976) Selective activation of the mesocortical DA system by stress. Nature 263:242–243PubMedCrossRefGoogle Scholar
  85. Tomie A, Miller WC, Dranoff E, Pohorecky LA (2006) Intermittent presentations of ethanol sipper tube induce ethanol drinking in rats. Alcohol Alcohol 41:225–230PubMedGoogle Scholar
  86. Treutlein J, Kissling C, Frank J, Wiemann S, Dong L, Depner M et al (2006) Genetic association of the human corticotropin releasing hormone receptor 1 (CRHR1) with binge drinking and alcohol intake patterns in two independent samples. Mol Psychiatry 11:594–602PubMedCrossRefGoogle Scholar
  87. Valdez GR, Koob GF (2004) Allostasis and dysregulation of corticotropin-releasing factor and neuropeptide Y systems: implications for the development of alcoholism. Pharmacol Biochem Behav 79:671–689PubMedCrossRefGoogle Scholar
  88. Valdez GR, Roberts AJ, Chan K, Davis H, Brennan M, Zorrilla EP et al (2002) Increased ethanol self-administration and anxiety-like behavior during acute ethanol withdrawal and protracted abstinence: regulation by corticotropin-releasing factor. Alcohol Clin Exp Res 26:1494–1501PubMedCrossRefGoogle Scholar
  89. Valdez GR, Sabino V, Koob GF (2004) Increased anxiety-like behavior and ethanol self-administraiton in dependent rats: reversal via corticotropin-releasing factor-2 receptor activation. Alcohol Clin Exp Res 28:865–872PubMedCrossRefGoogle Scholar
  90. Valentino RJ, Commons KG (2005) Peptides that fine-tune the serotonin system. Neuropeptides 39:1–8PubMedCrossRefGoogle Scholar
  91. Wanat MJ, Hopf FW, Stuber GD, Phillips PE, Bonci A (2008) Corticotropin-releasing factor increases mouse ventral tegmental area dopamine neuron firing through a protein kinase C-dependent enhancement of Ih. J Physiol 586:2157–2170PubMedCrossRefGoogle Scholar
  92. Wang B, Shaham Y, Zitzman D, Azari S, Wise RA, You ZB (2005) Cocaine experience establishes control of midbrain glutamate and dopamine by corticotropin-releasing factor: a role in stress-induced relapse to drug seeking. J Neurosci 25:5389–5396PubMedCrossRefGoogle Scholar
  93. Wang B, You ZB, Rice KC, Wise RA (2007) Stress-induced relapse to cocaine seeking: roles for the CRF(2) receptor and CRF-binding protein in the ventral tegmental area of the rat. Psychopharmacology (Berl) 193:283–294CrossRefGoogle Scholar
  94. Wayner MJ, Greenberg I (1972) Effects of hypothalamic stimulation, acclimation and periodic withdrawal on ethanol consumption. Physiol Behav 9:737–740PubMedCrossRefGoogle Scholar
  95. Weiss F, Parsons LH, Schulteis G, Hyytia P, Lorang MT, Bloom FE et al (1996) Ethanol self-administration restores withdrawal-associated deficiencies in accumbal dopamine and 5-hydroxytryptamine release in dependent rats. J Neurosci 16:3474–3485PubMedGoogle Scholar
  96. Weitemier AZ, Ryabinin AE (2006) Urocortin 1 in the dorsal raphe regulates food and fluid consumption, but not ethanol preference in C57BL/6J mice. Neuroscience 137:1439–1445PubMedCrossRefGoogle Scholar
  97. Wise RA (1973) Voluntary ethanol intake in rats following exposure to ethanol on various schedules. Psychopharmacologia 29:203–210PubMedCrossRefGoogle Scholar
  98. Wise RA (1996) Neurobiology of addiction. Curr Opin Neurobiol 6:243–251PubMedCrossRefGoogle Scholar
  99. Zorrilla EP, Koob GF (2004) The therapeutic potential of CRF1 antagonists for anxiety. Expert Opin Investig Drugs 13:799–828PubMedCrossRefGoogle Scholar
  100. Zorrilla EP, Koob GF (2010) Progress in corticotropin-releasing factor-1 antagonist development. Drug Discov Today 15:371–383PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  • Lara S. Hwa
    • 1
  • Joseph F. DeBold
    • 1
  • Klaus A. Miczek
    • 1
    • 2
  1. 1.Department of PsychologyTufts UniversityMedfordUSA
  2. 2.Department of NeuroscienceTufts UniversityBostonUSA

Personalised recommendations